Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient

Blood

Volumn 92, Issue 10, 1998, Pages 3515-3520

  Petersdorf, Effie W ^a,b   Gooley, Theodore A ^a   Anasetti, Claudio ^a   Martin, Paul J ^a   Smith, Anajane G ^a   Mickelson, Eric M ^a   Woolfrey, Ann E ^a   Hansen, John A ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA B ANTIGEN; HLA C ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN;

ALLELE; ARTICLE; BONE MARROW TRANSPLANTATION; CHRONIC MYELOID LEUKEMIA; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HISTOCOMPATIBILITY; HLA MATCHING; HUMAN; MAJOR CLINICAL STUDY; ORGAN DONOR; PRIORITY JOURNAL;

EID: 0032533228     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.10.3515.422k49_3515_3520     Document Type: Article

References (42)

1. Thomas E, Storb R, Clift RA, Fefer A, Johnson FL, Neiman PE, Lerner KG, Glucksberg H, Buckner CD: Bone-marrow transplantation. N Engl J Med 292:832, 895, 1975
2. Blume KG, Beutler E, Bross KJ, Chillar RK, Ellington OB, Fahey JL, Farbstein MJ, Forman SJ, Schmidt GM, Scott EP, Spruce WE, Turner MA, Wolf JL: Bone-marrow ablation and allogeneic marrow transplantation in acute leukemia. N Engl J Med 302:1041, 1980
3. Champlin R, Ho W, Arenson E, Gale RP: Allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic or accelerated phase. Blood 60:1038, 1982
4. Goldman JM, Apperley JF, Jones L: Bone marrow transplantation for patients with chronic myeloid leukemia. N Engl J Med 314:202, 1986
5. Forman SJ, Schmidt GM, Nademanee AP, Amylon MD, Chao NJ, Fahey JL, Konrad PN, Margolin KA, Niland JC, O'Donnell MR: Allogeneic bone marrow transplantation as therapy for primary induction failure for patients with acute leukemia. J Clin Oncol 9:1570, 1991
6. Gluckman E, Horowitz MM, Champlin RE, Hows JM, Bacigalupo A, Biggs, JC, Camitta BM, Gale RP, Gordon-Smith EC, Marmont AM: Bone marrow transplantation for severe aplastic anemia: influence of conditioning and graft-versus-host disease prophylaxis regimens on outcome. Blood 79:269, 1992
7. Beatty PG, Ash R, Hows JM, McGlave PB: The use of unrelated bone marrow donors in the treatment of patients with chronic myelogenous leukemia: Experience of four marrow transplant centers. Bone Marrow Transplant 4:287, 1989
8. O'Reilly RJ, Dupont B, Pahwa S, Grimes E, Smithwick EM, Pahwa R, Schwanz S, Hansen JA, Siegal FP, Sorell M, Svejgaard A, Jersild C, Thomsen M, Platz P, Esperance P, Good RA: Reconstitution in severe combined immunodeficiency by transplantation of marrow from an unrelated donor. N Engl J Med 297:1311, 1977
9. Mackinnon S, Hows JM, Goldman JM, Arthur CK, Hughes T, Apperley JF, Jones L, Batchelor JR, Brookes P, Catovsky D: Bone marrow transplantation for chronic myeloid leukemia: The use of histocompatible unrelated volunteer donors. Exp Hematol 18:421, 1990
10. Kernan NA, Bartsch G, Ash RC, Beatty PG, Champlin R, Filipovich A, Gajewski J, Hansen JA, Henslee-Downey J, McCullough J: Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 328:593, 1993
11. McGlave P, Bartsch G, Anasetti C, Ash R, Beatty P, Gajewski J, Keman NA: Unrelated donor marrow transplantation therapy for chronic myelogenous leukemia: Initial experience of the National Marrow Donor Program. Blood 81:543, 1993
12. Drobyski WR, Ash RC, Casper JT, McAuliffe T, Horowitz MM, Lawton C, Keever C, Baxter-Lowe LA, Camitta B, Garbrecht F: Effect of T-cell depletion as graft-versus-host disease prophylaxis on engraftment, relapse, and disease-free survival in unrelated marrow transplantation for chronic myelogenous leukemia. Blood 83:1980, 1994
13. Hansen JA, Gooley TA, Martin PJ, Appelbaum F, Chauncey TR, Clift RA, Petersdorf EW, Radich J, Sanders JE, Storb RF, Sullivan KM, Anasetti C: Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. N Engl J Med 338:962, 1998
14. Mason PM, Parham P: HLA class I region sequences, 1998. Tissue Antigens 51:417, 1998
15. Petersdorf EW, Longton GM, Anasetti C, Mickelson EM, Smith AG, Martin, PJ, Hansen JA: Definition of HLA-DQ as a transplantation antigen. Proc Natl Acad Sei USA 93:15358, 1996
16. Martin PJ, Hansen JA, Buckner CD, Sanders JE, Deeg HJ, Stewart P, Appelbaum KR, Clift R, Fefer A, Witherspoon RP: Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts. Blood 66:664, 1985
17. Storb R, Deeg HJ, Whitehead J, Appelbaum F, Beatty P, Bensinger W, Buckner CD, Clift R, Doney K, Farewell V: Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med 314:729, 1986
18. Dupont B, Braun DW, Yunis EJ, Carpenter CB: HLA-D by cellular typing, in Terasaki PI (ed): Histocompatibility Testing 1980. Los Angeles, CA, University of California, 1980, p 229
19. Petersdorf EW, Smith AG, Mickelson EM, Martin PJ, Hansen JA: Ten HLA-DR4 alleles defined by sequence polymorphisms within the DRB1 first domain. Immunogenetics 33:267, 1991
20. Petersdorf EW, Longton GM, Anasetti C, Mickelson EM, McKinney SK, Smith AG, Martin PJ, Hansen JA: Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors. Blood 89:1818, 1997
21. Scheltinga S, Van den Berg T, Versluis L, Avinens O, Eliaou JF, Hohnston-Dow L, Tilanus M: Subtyping of HLA-A2 by reversed dot blot and sequencing based typing: A comparative study, in Charron D (ed): HLA: Genetic Diversity of HLA. Functional and Medical Implications, vol 2. Paris, France, EDK, 1998, p 375
22. Krausa P, Stein J, McGinnis M: A sequencing based typing approach for high resolution definition of HLA-A locus alleles. Eur J Immunogen 25:46, 1998
23. Petersdorf EW, Smith AG, Mickelson EM, Longton GM, Anasetti C, Choo SY, Martin PJ, Hansen JA: The role of HLA-DPB1 disparity in the development of acute graft-versus-host disease following unrelated donor marrow transplantation. Blood 81:1923, 1993
24. Santamaria P, Reinsmoen NL, Lindstrom AL, Boyce-Jacino MT, Barbosa JJ, Paras AJ, McGlave PB, Rich SS: Frequent HLA class I and DP sequence mismatches in serologically (HLA-A, HLA-B, HLA-DR) and molecularly (HLA-DRB1, HLA-DQA1, HLA-DQB1) HLA-identical unrelated bone marrow transplant pairs. Blood 83:280, 1994
25. Goodrich JM, Bowden RA, Fisher L, Keller C, Schoch G, Meyers JD: Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant. Ann Intern Med 118:173, 1993
26. Slavin MA, Osborne B, Adams R, Levenstein MJ, Schoch HG, Feldman AR, Meyers JD, Bowden RA: Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation-A prospective, randomized, double-blind study. J Infect Dis 171:1545, 1995
27. Morton AJ, Gooley T, Hansen JA, Appelbaum FR, Bjerke JW, Clift R, Martin PJ, Petersdorf EW, Sanders JE, Storb R, Sullivan KM, Woolfrey A, Anasetti C: Association between pre-transplant interferonalpha and outcome after unrelated donor marrow transplantation for chronic myelogenous leukemia in chronic phase. Blood 92:394, 1998
28. Pepe MS, Longton G, Pettinger M, Mori M, Fisher LD, Storb R: Summarizing data on survival, relapse, and chronic graft-versus-host disease after bone marrow transplantation: Motivation for and description of new methods. Br J Haematol 83:602, 1993
29. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457, 1958
30. Sasazuki T, Juji T, Morishima Y, Kinukawa N, Kashiwabara H, Inoko H, Yoshida T, Kimura A, Akaza T, Kamikawaji N, Kodera Y, Takaku F: Importance of HLA class I allele matching for clinical outcome after unrelated donor hematopoietic stem cell transplantation. N Engl J Med (in press)
31. Rosenberg AS, Singer A: Cellular basis of skin allograft rejection: An in vivo model of immune-mediated tissue destruction. Annu Rev Immunol 10:333, 1992
32. Simpson E, Scott D, Chandler P: The male-specific histocompatibility antigen, H-Y: A history of transplantation, immune response genes, sex determination and expression cloning. Annu Rev Immunol 15:39, 1997
33. Rammensee H.-G, Friede T, Stevanovic S: MHC ligands and peptide motifs: First listing. Immunogenetics 41:178, 1995
34. Lanier LL, Gumperz JE, Parham P, Melero I, Lopez-Botet M, Phillips, JH: The NKB1 and HP-3E4 NK cells receptors are structurally distinct glycoproteins and independently recognize polymorphic HLA-B and HLA-C molecules. J Immunol 154:3320, 1995
35. Beatty PG, Mori M, Milford E: Impact of racial genetic polymorphism on the probability of finding an HLA-matched donor. Transplantation 60:778, 1995
36. Scharf SJ, Griffith RL, Erlich HA: Rapid typing of DNA sequence polymorphism at the HLA-DRB1 locus using the polymerase chain reaction and non-radioactive oligonucleotide probes. Hum Immunol 30:190, 1991
37. Molkentin J, Gorski J, Baxter-Lowe LA: Detection of 14 HLA-DQB1 alleles by oligotyping. Hum Immunol 31:114, 1991
38. Browning MJ, Krausa P, Rowan A, Bicknell DC, Bodmer JG, Bodmer WF: Tissue typing the HLA-A locus from genomic DNA by sequence-specific PCR: Comparison of HLA genotype and surface expression on colorectal tumor cell lines. Proc Natl Acad Sci USA 90:2842, 1993
39. Levine JE, Yang SY: SSOP typing of the Tenth International Histocompatibility Workshop reference cell lines for HLA-C alleles. Tissue Antigens 44:174, 1994
40. Fernandez-Vina M, Lazaro AM, Sun Y, Miller S, Forero L, Stastny P: Population diversity of B-locus alleles observed by high-resolution DNA typing. Tissue Antigens 45:153, 1995
41. Arguello R, Avakian H, Goldman JM, Madrigal JA: A novel method for simultaneous high resolution Identification of HLA-A, HLA-B and HLA-Cw alleles. Proc Natl Acad Sci USA 93:10961, 1996
42. Inamdar A, Sintasath DM, Husted L, Henson V, Ng J, Hartzman RJ, Hurley CK: Typing the HLA-B locus by a nested primer approach and oligonucleotide hybridization. Tissue Antigens 47:519, 1996